Great-West Lifeco Inc. (FRA:GWS)
| Market Cap | 44.49B +46.9% |
| Revenue (ttm) | 22.37B +3.2% |
| Net Income | 2.67B +12.6% |
| EPS | 2.89 +12.8% |
| Shares Out | n/a |
| PE Ratio | 16.68 |
| Forward PE | 14.10 |
| Dividend | 1.57 (3.16%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | n/a |
| Open | 49.52 |
| Previous Close | 49.45 |
| Day's Range | 49.52 - 49.52 |
| 52-Week Range | 31.00 - 49.72 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 6, 2026 |
About Great-West Lifeco
Great-West Lifeco Inc. engages in the life and health insurance, retirement savings, wealth and asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, critical illness, disability, health and dental protection, and creditor insurance products; and retirement savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations. It also provides individual product solutions and employer-sponsored retir... [Read more]
Financial Performance
In 2025, Great-West Lifeco's revenue was 35.45 billion, an increase of 2.04% compared to the previous year's 34.74 billion. Earnings were 3.96 billion, an increase of 0.51%.
Financial numbers in CAD Financial StatementsNews
Great-West Lifeco price target raised to C$77 from C$64 at RBC Capital
RBC Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$77 from C$64 and keeps a Sector Perform rating on the shares.
Great-West Lifeco price target raised to C$83 from C$78 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$83 from C$78 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$76 from C$70 at BMO Capital
BMO Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$76 from C$70 and keeps a Market Perform rating on the shares.
Great-West Lifeco price target raised to C$81 from C$75 at CIBC
CIBC raised the firm’s price target on Great-West Lifeco (GWLIF) to C$81 from C$75 and keeps an Outperformer rating on the shares.
Great-West Lifeco Slides: Investor presentation
Great-West Lifeco has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Great-West Lifeco price target raised to C$80 from C$73 at TD Securities
TD Securities raised the firm’s price target on Great-West Lifeco (GWLIF) to C$80 from C$73 and keeps a Buy rating on the shares.
Great-West Lifeco Earnings Call Transcript: Q1 2026
Double-digit earnings and EPS growth were achieved across all segments, with base ROE surpassing 19% for the first time. Strong capital generation, disciplined deployment, and robust segment performance support a positive outlook for 2026.
Great-West Lifeco Earnings release: Q1 2026
Great-West Lifeco released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Great-West Lifeco Slides: Q1 2026
Great-West Lifeco has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Great-West Lifeco price target raised to C$73 from C$70 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$73 from C$70 and keeps an Equal Weight rating on the shares.
Great-West Lifeco Inc. Profit Climbs In Q1
(RTTNews) - Great-West Lifeco Inc. (GWO.TO) revealed earnings for its first quarter that Increases, from the same period last year
Great-West Lifeco price target raised to C$78 from C$71 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$78 from C$71 and keeps an Outperform rating on the shares.
Great-West Lifeco Slides: Investor presentation
Great-West Lifeco has posted slides in relation to its latest quarterly earnings report, which was published on March 3, 2026.
Great-West Lifeco price target raised to C$64 from C$60 at RBC Capital
RBC Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$64 from C$60 and keeps a Sector Perform rating on the shares.
Great-West Lifeco price target lowered to C$66 from C$68 at BMO Capital
BMO Capital analyst Tom MacKinnon lowered the firm’s price target on Great-West Lifeco (GWLIF) to C$66 from C$68 and keeps a Market Perform rating on the shares. Published first on…
Great-West Lifeco price target raised to C$71 from C$70 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$71 from C$70 and keeps an Outperform rating on the shares.
Great-West Lifeco upgraded to Buy from Hold at Jefferies
Jefferies analyst John Aiken upgraded Great-West Lifeco (GWLIF) to Buy from Hold with a price target of C$70, up from C$67. Coming out of the third quarter, there were questions…
Great-West Lifeco Earnings Call Transcript: Q4 2025
Record base earnings and double-digit EPS growth were driven by strong performance across all segments, robust capital generation, and disciplined capital deployment. Empower and wealth businesses led growth, while capital was returned to shareholders through buybacks and a dividend increase.
Great-West Lifeco Earnings release: Q4 2025
Great-West Lifeco released its Q4 2025 earnings on February 12, 2026, summarizing the period's financial results.
Great-West Lifeco Slides: Q4 2025
Great-West Lifeco has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 12, 2026.
Great-West Lifeco price target raised to C$70 from C$68 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$70 from C$68 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$73 from C$67 at CIBC
CIBC raised the firm’s price target on Great-West Lifeco (GWLIF) to C$73 from C$67 and keeps an Outperformer rating on the shares.
Great-West Lifeco price target raised to C$70 from C$59 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$70 from C$59 and keeps an Equal Weight rating on the shares. The firm is “cautiously optimistic” on life…
Great-West Lifeco Earnings Call Transcript: Q3 2025
Record Q3 base earnings grew 15% year-over-year, with all segments contributing to strong results. Capital and risk solutions saw 20% earnings growth, and Empower Wealth surpassed $100 billion in assets. Share buybacks increased, and robust cash flow supports ongoing growth.
Great-West Lifeco Earnings release: Q3 2025
Great-West Lifeco released its Q3 2025 earnings on November 6, 2025, summarizing the period's financial results.